UAB to Start Human Trial on COVID-19 Vaccine Next Month
UAB researchers said today that they will begin Phase II human trials next month on a vaccine for COVID-19 developed by Oxford University with pharmaceutical giant AstroZeneca. About 500 participants will receive the vaccine locally as part of a nationwide trial of 33,000 participants. Read more.